FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046135465> ?p ?o ?g. }

• W2046135465 endingPage "269" @default.
• W2046135465 startingPage "263" @default.
• W2046135465 abstract "This clinical trial was designed to explore dose escalation of carboplatin and cyclophosphamide when supported with filgrastim. Twenty-seven patients who had advanced solid tumors received up to six cycles of treatment; a total of 92 cycles of chemotherapy were delivered. Two control groups received standard-dose carboplatin (300 mg/m2) and cyclophosphamide (600 mg/m2), with and without filgrastim. Subsequently, the doses of both carboplatin and cyclophosphamide were increased simultaneously by 50% of the standard dose in sequential cohorts. Doses of up to 2.5 times the standard dose were explored. A final dose of carboplatin, 600 mg/m2, and cyclophosphamide, 1,500 mg/m2, was tested in 4 patients. The duration of neutropenia was brief, even at the highest dose levels. The mean duration of grade 3 or 4 neutropenia was 5.8 days at standard dose without filgrastim and 5.4 days at 2.5 times standard dose with filgrastim. More severe neutropenia was more prolonged at higher doses but remained brief in duration. The mean duration of eutropenia of less than 100 × 106/l was 0.4 days at standard dose without filgrastim and 1.3 days at 2.5 times standard dose. There was no evidence of cumulative neutropenia over repeated cycles of treatment. In contrast, thrombocytopenia was both dose limiting and cumulative. The mean duration of grade 3 or 4 thrombocytopenia was 1.6 days at standard dose and 9.6 days at 2.5 times standard dose. An average of 2.3 platelet transfusions per cycle of treatment was required at the highest dose. Thrombocytopenia was worse with repetitive cycles of therapy. The mean duration of grade 3 or 4 thrombocytopenia was 2.2 days after the first cycle of chemotherapy and 7.8 days after cycle four. The maximum tolerated dose, as defined prospectively, was not reached but further dose escalation 1as not thought to be warranted because of the severity of thrombocytopenia. When supported with filgrastim, carboplatin and cyclophosphamide can be administered safely with substantially increased dose and acceptable toxicity." @default.
• W2046135465 created "2016-06-24" @default.
• W2046135465 creator A5014768914 @default.
• W2046135465 creator A5024253170 @default.
• W2046135465 creator A5031661938 @default.
• W2046135465 creator A5040769149 @default.
• W2046135465 creator A5043655365 @default.
• W2046135465 creator A5044010163 @default.
• W2046135465 creator A5060114622 @default.
• W2046135465 creator A5073049108 @default.
• W2046135465 creator A5085343063 @default.
• W2046135465 date "1998-06-01" @default.
• W2046135465 modified "2023-09-28" @default.
• W2046135465 title "Dose Escalation Study of Carboplatin and Cyclophosphamide With Filgrastim Support" @default.
• W2046135465 cites W1781086284 @default.
• W2046135465 cites W1851054576 @default.
• W2046135465 cites W2047859241 @default.
• W2046135465 cites W2061382718 @default.
• W2046135465 cites W2116996913 @default.
• W2046135465 cites W2138917119 @default.
• W2046135465 cites W2147034107 @default.
• W2046135465 cites W2159629353 @default.
• W2046135465 cites W2167805334 @default.
• W2046135465 cites W2330558238 @default.
• W2046135465 cites W2341557816 @default.
• W2046135465 cites W3005498893 @default.
• W2046135465 doi "https://doi.org/10.1097/00000421-199806000-00012" @default.
• W2046135465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9626795" @default.
• W2046135465 hasPublicationYear "1998" @default.
• W2046135465 type Work @default.
• W2046135465 sameAs 2046135465 @default.
• W2046135465 citedByCount "2" @default.
• W2046135465 crossrefType "journal-article" @default.
• W2046135465 hasAuthorship W2046135465A5014768914 @default.
• W2046135465 hasAuthorship W2046135465A5024253170 @default.
• W2046135465 hasAuthorship W2046135465A5031661938 @default.
• W2046135465 hasAuthorship W2046135465A5040769149 @default.
• W2046135465 hasAuthorship W2046135465A5043655365 @default.
• W2046135465 hasAuthorship W2046135465A5044010163 @default.
• W2046135465 hasAuthorship W2046135465A5060114622 @default.
• W2046135465 hasAuthorship W2046135465A5073049108 @default.
• W2046135465 hasAuthorship W2046135465A5085343063 @default.
• W2046135465 hasConcept C126322002 @default.
• W2046135465 hasConcept C141071460 @default.
• W2046135465 hasConcept C151032500 @default.
• W2046135465 hasConcept C2776694085 @default.
• W2046135465 hasConcept C2776755627 @default.
• W2046135465 hasConcept C2777063308 @default.
• W2046135465 hasConcept C2778239845 @default.
• W2046135465 hasConcept C2778850193 @default.
• W2046135465 hasConcept C2779171977 @default.
• W2046135465 hasConcept C2781451048 @default.
• W2046135465 hasConcept C42219234 @default.
• W2046135465 hasConcept C71924100 @default.
• W2046135465 hasConceptScore W2046135465C126322002 @default.
• W2046135465 hasConceptScore W2046135465C141071460 @default.
• W2046135465 hasConceptScore W2046135465C151032500 @default.
• W2046135465 hasConceptScore W2046135465C2776694085 @default.
• W2046135465 hasConceptScore W2046135465C2776755627 @default.
• W2046135465 hasConceptScore W2046135465C2777063308 @default.
• W2046135465 hasConceptScore W2046135465C2778239845 @default.
• W2046135465 hasConceptScore W2046135465C2778850193 @default.
• W2046135465 hasConceptScore W2046135465C2779171977 @default.
• W2046135465 hasConceptScore W2046135465C2781451048 @default.
• W2046135465 hasConceptScore W2046135465C42219234 @default.
• W2046135465 hasConceptScore W2046135465C71924100 @default.
• W2046135465 hasIssue "3" @default.
• W2046135465 hasLocation W20461354651 @default.
• W2046135465 hasLocation W20461354652 @default.
• W2046135465 hasOpenAccess W2046135465 @default.
• W2046135465 hasPrimaryLocation W20461354651 @default.
• W2046135465 hasRelatedWork W136411592 @default.
• W2046135465 hasRelatedWork W1975832547 @default.
• W2046135465 hasRelatedWork W1991613108 @default.
• W2046135465 hasRelatedWork W2032853726 @default.
• W2046135465 hasRelatedWork W2046135465 @default.
• W2046135465 hasRelatedWork W2053128632 @default.
• W2046135465 hasRelatedWork W2075557819 @default.
• W2046135465 hasRelatedWork W2158561707 @default.
• W2046135465 hasRelatedWork W2406808575 @default.
• W2046135465 hasRelatedWork W2604242146 @default.
• W2046135465 hasVolume "21" @default.
• W2046135465 isParatext "false" @default.
• W2046135465 isRetracted "false" @default.
• W2046135465 magId "2046135465" @default.
• W2046135465 workType "article" @default.